Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age (Pediatric Infectious Disease Journal, 2015)

(untitled) - Snape, M; Pollard, A; Voysey, M; Finn, A; Bona, G; Esposito, S; Principi, N; Diez-Domingo, J; Sokal, E; Kieninger, D; Prymula, R; Dull, P; et al.